Stonepine Capital Management, LLC

Position in SRZN — Surrozen, Inc./DE

CIK 1440771 BEND, OR

Position in SRZN

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$961,435

-$1,606,625 QoQ

Shares Held

33,005

-71.0% QoQ

Ownership

0.284%

of shares outstanding

% of Portfolio

0.29%

of 13F equity value

Holder Rank

#32

of 58 holders

Holding Since

Jun 2024

8 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Stonepine Capital Management, LLC holds $317,255,756 across 54 Biotechnology names. SRZN ranks #22 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RADX	Radiopharm Theranostics Ltd	51,000,000	$219,300,000
2	VSTM	Verastem, Inc.	3,302,300	$17,502,190
3	TENX	Tenax Therapeutics, Inc.	975,200	$15,593,448
4	ADMA	Adma Biologics, Inc.	740,000	$6,667,400
5	CAMP	Camp4 Therapeutics Corp	1,389,622	$6,128,233
6	NKTR	Nektar Therapeutics	85,000	$6,115,750
7	ZVRA	Zevra Therapeutics, Inc.	480,000	$4,473,600
8	CRBP	Corbus Pharmaceuticals Holdings, Inc.	383,462	$3,600,708

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$961,435	33,005	-71.0%	Shares	Sole	2026-05-14
2025-12-31	$2,568,060	113,631	-54.6%	Shares	Sole	2026-02-13
2025-09-30	$3,223,131	250,146	-18.3%	Shares	Sole	2025-11-13
2025-06-30	$2,735,899	306,029	-7.9%	Shares	Sole	2025-08-13
2025-03-31	$3,876,378	332,451	+16.3%	Shares	Sole	2025-05-14
2025-03-31	$3,332,218	285,782	+108.3%	Shares	Sole	2025-05-14
2024-12-31	$1,968,820	137,200	+24.7%	Shares	Sole	2025-02-14
2024-09-30	$1,317,800	110,000	+66.5%	Shares	Sole	2024-11-13
2024-06-30	$723,619	66,084	—	Shares	Sole	2024-08-21
No filing history on record for this holder in this stock.